Lilly invests $3 billion to expand Wisconsin plant as obesity drug demand soars

Eli Lilly announced a $3 billion investment to expand its Pleasant Prairie, Wisconsin manufacturing plant, which it acquired earlier this year.

The expansion will increase production of its weight-loss drug Zepbound, diabetes treatments, and other medicines.

This investment, Lilly’s largest outside Indiana, aims to meet soaring demand for drugs like Zepbound and Mounjaro, which faced shortages earlier this year.

Lilly has committed over $23 billion to manufacturing expansions since 2020, CNBC has reported.

read more: https://www.cnbc.com/2024/12/05/lilly-invests-3-billion-to-expand-wisconsin-plant-as-obesity-drug-demand-soars-.html

Links for B.C.

Visit My Website
https://bcbegley.com

Follow Me On Facebook
https://www.facebook.com/B.C.Begley

Subscribe To My Patreon
https://www.patreon.com/bcbegley

Watch Me On YouTube
https://www.youtube.com/channel/UCGoUf-QQTlTN-BIh3ERCE9A

Follow Me On Twitter
https://twitter.com/BC_News1

Watch Me On Rumble
https://rumble.com/c/c-280191

Follow Me On Gab
https://gab.com/BC_Begley

Follow Me On Truth Social
https://truthsocial.com/@BC_Begley

Follow Me On BlueSky
https://bsky.app/profile/bcbegley.bsky.social